PHI Biomed

PHI Biomed is a South Korean biotechnology company focused on developing advanced drug delivery systems and smart medical devices. Founded by Professor Sei Kwang Hahn of POSTECH, the company utilizes a proprietary hyaluronic acid (HA) platform to enable the sustained and targeted delivery of various therapeutics, including proteins, peptides, and mRNA. Their innovative product portfolio includes smart contact lenses for non-invasive glucose monitoring and drug delivery for glaucoma, as well as transdermal systems for hair loss and obesity. PHI Biomed aims to improve patient quality of life by replacing frequent injections with more convenient and effective delivery modalities. The company maintains strong academic ties with institutions like Stanford and Harvard to advance its bio-nanotechnology applications.